SEC Form 4 · accession 0001179110-16-019930

ABBOTT LABORATORIES · ABT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Vice President, Controller

Period of report

Feb 19, 2016

Accepted (ET)

Feb 23, 2016 · 6:13 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000001800

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common shares without par value^F1	Feb 19, 2016	A	9,505	$0.00	A	89,190	D
Common shares without par value^F2	holding	—	—		—	16,242	I	Profit Sharing Trust
Common shares without par value^F3	holding	—	—		—	500	I	By daughter
Common shares without par value^F3	holding	—	—		—	500	I	By daughter

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Option (right to buy)^F4	$38.40	Feb 19, 2016	A	83,333	A	Feb 19, 2017	Feb 18, 2026	Common shares	83,333	83,333	D

F1These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
F2Balance in the Abbott Laboratories Stock Retirement Trust as of February 19, 2016.
F3The reporting person disclaims beneficial ownership of all securities held by his daughter.
F4Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 27,778 on 02/19/2017, 27,777 on 02/19/2018, and 27,778 on 02/19/2019.